Hyponatremia - 27 Studies Found Status Study Terminated Study Name: Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia Condition: Hyponatremia Date: 2012-06-20 Interventions: Drug: Tolvaptan 15 mg once dai Completed Study Name: An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2006-09-21 Interventions: Drug: conivaptan IV Other Names: Completed Study Name: Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2006-09-22 Interventions: Drug: YM087 Completed Study Name: Postoperative Hyponatremia - Are There Gender Differences? Condition: Hyponatremia Date: 2008-03-10 Interventions: Procedure: Fluid administration Completed Study Name: Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2007-05-22 Interventions: Drug: Conivaptan premix bag Completed Study Name: THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Condition: Hyponatremia Date: 2007-12-19 Interventions: Drug: lixivaptan Oral Capsule Completed Study Name: A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2015-05-08 Interventions: Drug: Tolvaptan Completed Study Name: Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2013-12-11 Interventions: Drug: Tolvaptan SAMSCA® Other Name: SAMSCA® Completed Study Name: An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia Condition: Hyponatremia Date: 2013-12-18 Interventions: Drug: Tolvaptan Tolvaptan 3.75-, 7.5-, 15-, and 30-mg spra Completed Study Name: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia Condition: Euvolemic Hyponatremia Date: 2009-04-06 Interventions: Drug: Lixivaptan Capsules, 25m <<< Previous | Next >>>
